---
layout: page
title: Special Labs
has_children: true
nav_order: 2
---
# Special Labs ðŸ”¬

## FoundationOne CDx
FoundationOne CDx is a genomic profiling test for solid tumors, identifying molecular alterations to guide targeted and immunotherapy treatments.
> [Order FoundationOne CDx on OncoEMR](/docs/guide/foundationone.html)

- [FoundationOne Portal](https://home.foundationmedicine.com/login){:target="_blank" rel="noopener noreferrer"}
- [Requisition Form](https://assets.ctfassets.net/w98cd481qyp0/6owgilIzUgyTujIVcRHTJs/13884484d7509d0561a9ad7bf20a483b/Universal_TRF_Interactive.pdf){:target="_blank" rel="noopener noreferrer"}
- [Specimen Release Form](https://assets.ctfassets.net/w98cd481qyp0/7JzKC8TNALu7FWAcxsziqb/374fbe590e03b2d5decab38d05777e27/Specimen_Release_Consent_Form.pdf){:target="_blank" rel="noopener noreferrer"}
- [FoundationOne ABN](https://assets.ctfassets.net/w98cd481qyp0/2sDK3JAu6WQrGirc2OnAcr/e9a477779c3e75525c2847a36e44c722/Medicare_ABN_INTERACTIVE_ABNEnglish_01312026_508_DIGITAL.pdf){:target="_blank" rel="noopener noreferrer"}

## Guardant Health
Guardant Health provides advanced liquid biopsy tests such as Guardant 360 and Guardant Reveal for genomic profiling and cancer management.
> [Order Guardant Health on OncoEMR](/docs/guide/guardant.html)

- [Guardant Health Portal](https://portal.guardanthealth.com/sign_in){:target="_blank" rel="noopener noreferrer"}
- [Guardant ABN](https://www.guardantcomplete.com/assets/pdf/FRM-000123_R7_Advance_Beneficiary%20Notice_of_Noncoverage.pdf){:target="_blank" rel="noopener noreferrer"}

## Signatera
Signatera is a personalized test for detecting molecular residual disease and monitoring recurrence in cancer patients.
- [Signatera Portal](https://oncology.natera.com/){:target="_blank" rel="noopener noreferrer"}
- [Signatera Requisition Form](/assets/docs/signatera_req.pdf){:target="_blank" rel="noopener noreferrer"}

## Invitae
Invitae offers genetic diagnostics for various conditions, including cancer, to assist in treatment decisions.
- [Invitae Portal](https://www.invitae.com/en/profile/signin){:target="_blank" rel="noopener noreferrer"}
- [Invitae Requisition](/assets/docs/invitae_req.pdf){:target="_blank" rel="noopener noreferrer"}
- [Invitae Consent](/assets/docs/invitae_consent.pdf){:target="_blank" rel="noopener noreferrer"}

## Oncotype DX
Oncotype DX is a genomic test used in breast cancer to assess recurrence risk and chemotherapy benefits.
- [Oncotype DX Portal](https://online.genomichealth.com/Login.aspx){:target="_blank" rel="noopener noreferrer"}
- [Oncotype DX Requisition](https://precisiononcology.exactsciences.com/-/media/Project/PrecisionOncology/PrecisionOncology/Files/Pdf/GHI003_ODXBRS_RequisitionForm.pdf?rev=1d4e3e90b80e4064a481935660f39ac6&hash=E780578F1AA4EF7E41F3DB2EB7F2DA90){:target="_blank" rel="noopener noreferrer"}

## Breast Cancer Index
The Breast Cancer Index predicts recurrence risk in hormone-receptor-positive breast cancer and evaluates benefits of extended anti-hormonal therapy.
- [BCI Portal](https://biotheranostics.my.site.com/s/login/){:target="_blank" rel="noopener noreferrer"}
- [BCI Requisition](https://www.breastcancerindex.com/test-form.pdf){:target="_blank" rel="noopener noreferrer"}
